These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14307763)

  • 1. [METHYLHYDRAZINE IN THE TREATMENT OF SOLID TUMORS].
    BRULE G; SCHLUMBERGER JR; GRISCELLI C
    Pathol Biol; 1965 Feb; 13():192-7. PubMed ID: 14307763
    [No Abstract]   [Full Text] [Related]  

  • 2. [CLINICAL TRIALS OF A METHYLHYDRAZINE DERIVATIVE AND ITS COMBINATION WITH TELECOBALT THERAPY].
    JACOB P; ABATUCCI JS; VIALLANEIX JP
    J Belge Radiol; 1964; 47():896-905. PubMed ID: 14262755
    [No Abstract]   [Full Text] [Related]  

  • 3. A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.
    BRUNNER KW; YOUNG CW
    Ann Intern Med; 1965 Jul; 63():69-86. PubMed ID: 14305970
    [No Abstract]   [Full Text] [Related]  

  • 4. [FIRST EVALUATION OF A METHYLHYDRAZINE IN THE TREATMENT OF MALIGNANT GRANULOMA. PRELIMINARY CLINICAL STUDY].
    PAOLO I; GIUSEPPE M
    Haematologica; 1964; 49():831-50. PubMed ID: 14293739
    [No Abstract]   [Full Text] [Related]  

  • 5. [TRIAL TREATMENT BY A METHYLHYDRAZINE OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS AND LEUKEMIAS].
    MATHE G; BERUMEN L; SCHWEISGUTH O; BRULE G; SCHNEIDER M; AMIEL JL; SCHWARZENBERG L
    Nouv Rev Fr Hematol; 1964; 4():327-9. PubMed ID: 14148296
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDIES ON THE CYTOSTATIC MECHANISM OF ACTION OF METHYLHYDRAZINE].
    WEITZEL G; SCHNEIDER F; FRETZDORFF AM; SEYNSCHE K; FINGER H
    Hoppe Seylers Z Physiol Chem; 1964; 336():271-82. PubMed ID: 14236184
    [No Abstract]   [Full Text] [Related]  

  • 7. THE TUMOR-INHIBITORY EFFECTS OF THE METHYLHYDRAZINE DERIVATIVE RO 4-6467/1 (NSC-77213).
    BOLLAG W
    Cancer Chemother Rep; 1963 Dec; 33():1-4. PubMed ID: 14102078
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON THE PROBLEM OF THE BIOCHEMICAL EFFECT OF A NEW CYTOSTATIC AGENT, RO 4-6467, FROM THE CLASS OF METHYLHYDRAZINE DERIVATIVES].
    OBRECHT P; STRICKSTROCK KH; WOENCKHAUS JW
    Chemotherapia (Basel); 1964; 20():106-13. PubMed ID: 14164293
    [No Abstract]   [Full Text] [Related]  

  • 9. [RESULTS OF CLINICAL TESTS OF A NEW CYTOSTATIC SUBSTANCE FROM THE METHYLHYDRAZINE SERIES (NATULAN)].
    BEGEMANN H; BLUM KU; FELLMER KE; FOELSCH E; GERHARTZ H; GRUNZE H; HAUSMANN K; HENNES R; JUENGLING W; KLEIBEL F; KOERTGE P; MARING H; MARTIN H; OBRECHT P; OSTEN W; PABST HW; POLIWODA H; SCHUBERT JC; SEIDL S; SPECHTER HJ; STRICKSTROCK KH; WITTE S; DREWS J
    Med Klin; 1965 Jun; 60():960-4. PubMed ID: 14304965
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of the immunological reaction by methylhydrazines, a new class of antitumour agents.
    BOLLAG W
    Experientia; 1963 Jun; 19():304-5. PubMed ID: 13968616
    [No Abstract]   [Full Text] [Related]  

  • 11. PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213).
    MARTZ G; D ALESSANDRI A; KEEL HJ; BOLLAG W
    Cancer Chemother Rep; 1963 Dec; 33():5-14. PubMed ID: 14102085
    [No Abstract]   [Full Text] [Related]  

  • 12. RESPONSE OF PRIMARY UNKNOWN CANCERS TO TREATMENT WITH 5-FLUOROURACIL (NSC-19893).
    JOHNSON RO; CASTRO R; ANSFIELD FJ
    Cancer Chemother Rep; 1964 May; 38():63-4. PubMed ID: 14167470
    [No Abstract]   [Full Text] [Related]  

  • 13. The reaction of peptides and insulin with methylhydrazine.
    BRADBURY JH
    Biochem J; 1958 Oct; 70(2):252-4. PubMed ID: 13584333
    [No Abstract]   [Full Text] [Related]  

  • 14. THE INDICATIONS FOR 5-FLUOROURACIL IN THE TREATMENT OF BREAST CANCER.
    ANSFIELD FJ
    Geriatrics; 1965 Mar; 20():250-3. PubMed ID: 14261250
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives.
    BOLLAG W; GRUNBERG E
    Experientia; 1963 Mar; 19():130-1. PubMed ID: 13968615
    [No Abstract]   [Full Text] [Related]  

  • 16. [TRIAL TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS AND LEUKEMIAS WITH A METHYLHYDRAZINE. STUDY BASED ON 100 PATIENTS].
    MATHE G; BERUMEN L; SCHWEISGUTH O; SCHNEIDER M; AMIEL JL; CATTAN A; SCHWARZENBERG L; BRULE G
    Presse Med (1893); 1964 Jun; 72():1641-4. PubMed ID: 14151508
    [No Abstract]   [Full Text] [Related]  

  • 17. ALKYLATING AGENTS, ANTI-METABOLITES, ALKALOIDS AND X-RAYS IN THE TREATMENT OF INOPERABLE BRONCHOGENIC CARCINOMA.
    ARONOVITCH M; BOUCHARD J; GROSZMAN M; MEAKINSS JF; HAZEL J; JALIL A
    Med Serv J Can; 1964 May; 20():471-82. PubMed ID: 14161703
    [No Abstract]   [Full Text] [Related]  

  • 18. SIDE REACTIONS TO THE CHEMOTHERAPY OF SOLID TUMORS.
    SCHROEDER JM
    GP; 1965 Apr; 31():87-91. PubMed ID: 14261261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].
    Mathe G; Schneider M; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Concours Med; 1965 Jul; 87(27):4555-62. PubMed ID: 5841618
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylhydrazine derivatives, a new class of cytotoxic agents.
    ZELLER P; GUTMANN H; HEGEDUS B; KAISER A; LANGEMANN A; MULLER M
    Experientia; 1963 Mar; 19():129. PubMed ID: 14003433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.